sci-news.jpeg

sci-news

shimin.jpeg

shimin

eppharmaline.gif

eppharmaline

findat.jpeg

findat

yakuzemi.png

yakuzemi

new-lifescience.gif

new-lifescience

biopharmaceuticals.gif

biopharmaceuticals

jssx36.png

jssx36

convention.jpeg

convention

jshp2022-thk.png

jshp2022-thk

jasdi24.png

jasdi24

General information

Announcements(0)

Greetings from Chair

Overview

Registration

General information 2

Abstract Submission (Oral/Poster Presentation)

Program

Sessions

Search presentations

pharm142_en.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts. If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts. We will reply after confirming that you were a participant. Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Download PDF for print

Timetable

Development of a novel in vitro biomimetic evaluation system specialized for nanomaterials

In recent years, the global market scale of nanomaterials has been increasing year by year, and there is a wide range of demand for their use in daily life. In response to the growing international need for risk assessment of concern due to nanomaterials exposure, evaluation methods are being developed in a direction that extends the existing framework for risk assessment and management of chemicals. In 2019, nanomaterials will become a full-fledged subject of the European REACH registration system, and the development and improvement of OECD test method guidelines are being promoted at a rapid pace, mainly in Europe, and international cooperation on the safety of nanomaterials is also being promoted in Japan. From the toxicological point of view of nanomaterials, there are concerns about biological effects due to the significant influence of physical properties on bioaccumulation and surface activity, but standardized evaluation methods have not yet been established. In this symposium, we will invite experts in the fields of in vivo/in vitro/in silico evaluation to give lectures on the current status of toxicity evaluation methods for nanomaterials using various approaches.

Risk assessment of nanomaterials and future challenges

The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation Information

[S09-5]Development of a novel in vitro biomimetic evaluation system specialized for nanomaterials

Password required to view